Daren Shaw - Ensign Independent Director
| ENSG Stock | USD 117.78 0.53 0.45% |
Director
Mr. Daren J. Shaw is Independent Director of The Ensign Group, Inc. Mr. Shaw has served as a member of our Board of Directors since March 2012. Mr. Shaw has served for more than 33 years in leadership capacities with several financial services firms. He currently serves as a Managing Director of the Investment Banking Group at D.A. Davidson Co., a middlemarket fullservice investment banking firm. During his term as Managing Director at D.A. Davidson Co., Mr. Shaw has served on the Senior Management Committee and Board of Directors and as the lead investment banker in a wide variety of transactions including public stock offerings, private placements, and mergers and acquisitions. Mr. Shaw also served for 12 years with Pacific Crest Securities, in various roles, including Managing Director since 2012.
| Age | 61 |
| Tenure | 12 years |
| Address | 29222 Rancho Viejo Road, San Juan Capistrano, CA, United States, 92675 |
| Phone | 949 487 9500 |
| Web | https://ensigngroup.net |
Latest Insider Transactions
Shaw is also serving as a member of the board of directors of Profire Energy, Inc., a NASDAQ company. His service as our Audit Committee chairman and as a director of investment banking firms provide valuable financial understanding. We believe that Mr. Shaw’s extensive experience and leadership in the financial services industry supports the conclusion that he should serve as one of our directors.Daren Shaw Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daren Shaw against Ensign stock is an integral part of due diligence when investing in Ensign. Daren Shaw insider activity provides valuable insight into whether Ensign is net buyers or sellers over its current business cycle. Note, Ensign insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ensign'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daren Shaw over six months ago Acquisition by Daren Shaw of 65322 shares of Profire Ene subject to Rule 16b-3 |
Ensign Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1528 %, meaning that it created $0.1528 on every $100 dollars invested by stockholders. Ensign's management efficiency ratios could be used to measure how well Ensign manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ensign's Return On Tangible Assets are most likely to slightly decrease in the upcoming years. The Ensign's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.07. At this time, Ensign's Total Current Assets are most likely to increase significantly in the upcoming years. The Ensign's current Non Current Assets Total is estimated to increase to about 3.3 B, while Intangible Assets are projected to decrease to roughly 6.2 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Katherine Davisson | Select Medical Holdings | 53 | |
| EPerot Bissell | Acadia Healthcare | 58 | |
| Linda Hall | Amedisys | 68 | |
| Robert Frome | Healthcare Services Group | 80 | |
| Andrew Adams | National HealthCare | 72 | |
| John Briggs | Healthcare Services Group | 67 | |
| James Dalton | Select Medical Holdings | 73 | |
| Adam Feinstein | Surgery Partners | 45 | |
| Ziad Mirza | InnovAge Holding Corp | 53 | |
| Nathaniel Zilkha | Amedisys | 41 | |
| Christopher Gordon | Surgery Partners | 44 | |
| Lawrence Gibbs | Universal Health Services | 48 | |
| Donald Correll | Encompass Health Corp | 70 | |
| Steven Geringer | Addus HomeCare | 72 | |
| Maria Singer | Universal Health Services | 46 | |
| Darin Gordon | Addus HomeCare | 47 | |
| Jude Visconto | Healthcare Services Group | 44 | |
| Matthew Lozow | Surgery Partners | 37 | |
| Daniela Castagnino | Healthcare Services Group | 43 | |
| Warren Nimetz | Universal Health Services | 64 | |
| Christopher Reidy | Encompass Health Corp | 64 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0418 |
Ensign Group Leadership Team
Elected by the shareholders, the Ensign's board of directors comprises two types of representatives: Ensign inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ensign. The board's role is to monitor Ensign's management team and ensure that shareholders' interests are well served. Ensign's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ensign's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Beverly Wittekind, General Counsel and VP | ||
| Barry Smith, Independent Director | ||
| Daren Shaw, Independent Director | ||
| Malene Davis, Director | ||
| Ann Blouin, Director | ||
| Barry Port, COO of Ensign Services, Inc | ||
| Roy Christensen, Co-Founder and Chairman | ||
| Christopher Christensen, Co-Founder, CEO and President Director and Member of Quality Assurance and Compliance Committee | ||
| Chad Keetch, Executive VP and Secretary | ||
| Suzanne Snapper, Executive CFO | ||
| Lee Daniels, Independent Director | ||
| Kevin Reese, President Inc | ||
| Spencer Burton, President COO | ||
| John Nackel, Independent Director | ||
| Antoinette Hubenette, Independent Director |
Ensign Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ensign a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0418 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 7.94 B | ||||
| Shares Outstanding | 56.9 M | ||||
| Shares Owned By Insiders | 3.48 % | ||||
| Shares Owned By Institutions | 97.45 % | ||||
| Number Of Shares Shorted | 3.24 M | ||||
| Price To Earning | 29.50 X |
Pair Trading with Ensign
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ensign position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensign will appreciate offsetting losses from the drop in the long position's value.Moving together with Ensign Stock
| 0.68 | DRRX | Durect Earnings Call This Week | PairCorr |
Moving against Ensign Stock
| 0.47 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Ensign could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ensign when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ensign - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Ensign Group to buy it.
The correlation of Ensign is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ensign moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ensign Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ensign can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in The Ensign Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Ensign Stock analysis
When running Ensign's price analysis, check to measure Ensign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensign is operating at the current time. Most of Ensign's value examination focuses on studying past and present price action to predict the probability of Ensign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensign's price. Additionally, you may evaluate how the addition of Ensign to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Ensign's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensign. If investors know Ensign will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensign listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 0.233 | Earnings Share 3.65 | Revenue Per Share 66.945 | Quarterly Revenue Growth 0.211 |
The market value of Ensign Group is measured differently than its book value, which is the value of Ensign that is recorded on the company's balance sheet. Investors also form their own opinion of Ensign's value that differs from its market value or its book value, called intrinsic value, which is Ensign's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensign's market value can be influenced by many factors that don't directly affect Ensign's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensign's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensign is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensign's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.